However, similar exclusion of families carrying APC, MUTYH or POLE and POLD1 mutations because known cancers other than CRC are rare or unknown in these syndrome, and exclusion based on CRC would have defeated the purpose. This evidence concerns the gene POLE and colorectal carcinoma.